Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bryan Arnold who wrote (4336)	5/19/1998 3:57:00 PM
From: Robert L. Ray	Read Replies (2) of 6136

>I still don't understand how they are going to only be able to grow >their earnings by 100% from now until the year 2002. I would think >that it would be much higher then that. It would appear the reason is the marketing deals with Japan Tobacco and Roach for the Japanese and European sales. Sheese the Roche deal sounds awful from an AGPH standpoint. It basicaly amounts to a 10% royalty on sales is what the article said. Does this sound ridiculously low to anyone else? Looks like they could have cut a better deal than that.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next